PGF and central nervous system cancer: Further, the treatment of glioma cells with an anti-PlGF antibody (TB-403), a (PlGF)-specific inhibitor, completely suppressed the expression of the TGF-β, while the exposure of glioma cells to PlGF, upregulated the expression of the TGF-β [215] (Figure 2).